Abeona Therapeutics Inc. ABEO
4.20 USD -0.15 -3.56%
As of Nov 2, 11:19 AM ET
- YTD
- -20.40%
- 1 year
- -12.79%
- Open
- 4.43
- Prev close
- 4.35
- Mkt cap
- 240.17M
- Vol
- 271.08K
- Avg vol
- 1.35M
- EPS
- -1.18
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.19
- High
- 4.46
- Forward P/E
- -3.84
- Beta
- 1.50
- Short ratio
- 10.79
- Inst. own
- 77.54%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 6.15
- 200-d avg
- 5.64
- 1y target
- 16.75
MAX chart
Chart tools
Chart is warming up
The all-time price history for ABEO has not been loaded yet. Try again in a moment.
Altman Z-Score
-3.48 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 3
P/E 3.9×
P/S 47.9×
P/B 1.8×
P/FCF -3.3×
EV/EBITDA 2.9×
EV/Sales 38.8×
FCF Yield -30.2%
Gross Margin 73.7%
Operating Margin -1536.9%
Net Margin 1223.1%
ROE 44.7%
ROIC -44.0%
ROA 32.4%
Revenue 0.0%
Operating Income -39.3%
EPS (diluted) 165.2%
Free Cash Flow -44.2%
Current Ratio 6.9×
Quick Ratio 6.7×
Debt / Equity 0.2×
Net Debt / EBITDA -0.7×
Interest Coverage -23.9×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31